Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
Department of Radiation Physics, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
J Cancer Res Ther. 2023 Oct 1;19(7):1844-1851. doi: 10.4103/jcrt.jcrt_1664_21. Epub 2023 Apr 26.
Radical chemoradiation is the standard of treatment for locally advanced squamous cell carcinoma of esophagus and for patients with operable disease, but who are medically unfit or unwilling for surgery. As the esophagus is a central organ, the planning target volume (PTV) is central, lies close to the spinal cord and heart, and is surrounded by the lung, which is a radiosensitive organ. Irradiation of these critical structures is reduced by the use of three-dimensional conformal radiation therapy (3DCRT). Intensity-modulated radiation therapy (IMRT) has the potential to improve the uniformity of dose distribution to the tumor and reduce the dose received by surrounding normal tissues.
All cases of squamous cell carcinoma esophagus treated with radical chemoradiation to a dose of 50 Gy in 25 fractions using 3DCRT technique from January 2018 to July 2019 were included. IMRT plans were generated for these cases.The parameters that represent dose distribution to the target volume and the dose received by the organs at risk were obtained from the dose-volume histogram. The difference in the mean values of the parameters between the two techniques was calculated. The statistical significance of the difference was determined using Student's t-test and Wilcoxon signed-rank test.
The volume of PTV receiving 105% and 107% of prescribed dose was significantly lower with IMRT (3.540% and 0.008%, respectively) compared to 3DCRT (7.654% and 0.623%). The homogeneity index was better with IMRT (0.088 vs. 0.107) than 3DCRT. Conformity index was found to be better with IMRT (1.149 vs. 1.573). Mean heart dose (18.216 vs. 24.591 Gy) and the volume of heart receiving 30 Gy were reduced with IMRT. The volume of lung receiving 20 Gy and the volume receiving 5 Gy were not significantly different between 3DCRT and IMRT. Maximum dose to spinal cord was similar with 3DCRT and IMRT.
IMRT avoids areas of excessive irradiation within the PTV. IMRT improves dose conformity to the target volume and homogeneity of dose distribution within the PTV. The cardiac dose is significantly reduced with IMRT. The mean lung dose remains similar to 3DCRT. There is no significant increase in the volume of lung receiving low-dose radiation with IMRT.
根治性放化疗是局部晚期食管鳞状细胞癌和可手术患者的标准治疗方法,但对于不适合或不愿意接受手术的患者。由于食管是中央器官,因此计划靶区(PTV)位于中央,靠近脊髓和心脏,周围是肺,肺是一种对辐射敏感的器官。三维适形放疗(3DCRT)可减少对这些关键结构的照射。调强放疗(IMRT)有可能改善肿瘤的剂量分布均匀性,并降低周围正常组织的剂量。
纳入 2018 年 1 月至 2019 年 7 月期间使用 3DCRT 技术对食管鳞状细胞癌进行根治性放化疗,剂量为 50 Gy,共 25 个分数的所有病例。为这些病例生成了 IMRT 计划。从剂量-体积直方图中获得代表靶区剂量分布和危险器官受照剂量的参数。计算两种技术之间参数平均值的差异。使用学生 t 检验和 Wilcoxon 符号秩检验确定差异的统计学意义。
与 3DCRT 相比,IMRT 时 PTV 接受 105%和 107%规定剂量的体积明显更低(分别为 3.540%和 0.008%)。IMRT 的均匀性指数更好(0.088 比 0.107)。与 3DCRT 相比,IMRT 的适形指数更好(1.149 比 1.573)。IMRT 可降低心脏平均剂量(18.216 比 24.591 Gy)和 30 Gy 心脏受照体积。3DCRT 和 IMRT 之间 20 Gy 肺受照体积和 5 Gy 肺受照体积无显著差异。脊髓最大剂量与 3DCRT 和 IMRT 相似。
IMRT 避免了 PTV 内的过度照射区域。IMRT 改善了靶区的剂量适形性和 PTV 内的剂量分布均匀性。IMRT 可显著降低心脏剂量。平均肺剂量与 3DCRT 相似。IMRT 不会增加低剂量照射的肺体积。